Sweden· SE-20151210000015
Cuprior 150 mg Tablett
A medicinal product containing trientine, registered in Sweden by Orphalan.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Trientine
- Manufacturer
- Orphalan
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20151210000015
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Trientine in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCuprior 150mg tabletsOrphalan UK Ltd
- NetherlandsCuprior150 mg, tabletGMP-Orphan SAS
- NorwayCupriorOrphalan
- SwitzerlandCuprior
- CzechiaCUFENCEUnivar Solutions B.V., Rotterdam
- United StatesSyprineBausch Health US LLC
- FinlandCufenceUnivar Solutions BV
- FranceCUFENCE 100 mg, géluleUNIVAR SOLUTIONS (PAYS-BAS)
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Aveleris, Trientin
- Belgium · Aveleris
- Czechia · Trientine Tillomed
- Germany · Aveleris, Trientin Waymade
- Denmark · Trientin Waymade, Trientine Tillomed
- Spain · Trientina
- Finland · Trientine Tillomed, Trientine Waymade
- France · Trientine Tillomed, Trientine Waymade
- United Kingdom (Northern Ireland) · Trientine, Trientine Dihydrochloride Tillomed
- Greece · Trientine Tillomed, Trientine Waymade
- Ireland · Trientine Tillomed, Trientine Tillomed Pharma
- Iceland · Cufence, Cuprior
- Italy · Trientina Ideogen, Trientina Waymade
- Liechtenstein · Cufence, Cuprior
- Luxembourg · Aveleris
- Netherlands · Aveleris, Trientine Waymade
- Norway · Cufence, Cuprior
- Portugal · Trientina Tillomed, Trientina Waymade
- Slovakia · Trientine Tillomed
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6db096f7-ae05-49c4-9462-0bd7ed57102c GET /v1/drugs/6db096f7-ae05-49c4-9462-0bd7ed57102c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20151210000015",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20151210000015",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/cuprior-epar-product-information_sv.pdf"
}See everything about trientine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.